Nicholas Pajewski

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Eyenovia
    Topic:
    Ophthalmic drug delivery technologies
    Date added:
    05/03/2022
    Date updated:
    05/03/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Ocuphire Pharma
    Topic:
    Therapies for the treatment of refractive and retinal eye disorders.
    Date added:
    05/03/2022
    Date updated:
    05/03/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Longeveron
    Topic:
    Cell-based therapies
    Date added:
    05/03/2022
    Date updated:
    05/03/2022
    Relationship end date:
    11/22/2021
Return to ANPA Annual Scientific Meeting 2022: Health Care Delivery During Crisis and Conflict (JS2206B)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.